Rituximab Treatment and Long-term Outcome of Patients With Autoimmune Encephalitis: Real-world Evidence From the GENERATE Registry

BACKGROUND AND OBJECTIVES: To determine the real-world use of rituximab in autoimmune encephalitis (AE) and to correlate rituximab treatment with the long-term outcome. METHODS: Patients with NMDA receptor (NMDAR)-AE, leucine-rich glioma-inactivated-1 (LGI1)- AE, contactin-associated protein-like-2...

Descripción completa

Detalles Bibliográficos
Autores principales: Thaler, Franziska S., Zimmermann, Luise, Kammermeier, Stefan, Strippel, Christine, Ringelstein, Marius, Kraft, Andrea, Sühs, Kurt-Wolfram, Wickel, Jonathan, Geis, Christian, Markewitz, Robert, Urbanek, Christian, Sommer, Claudia, Doppler, Kathrin, Penner, Loana, Lewerenz, Jan, Rößling, Rosa, Finke, Carsten, Prüss, Harald, Melzer, Nico, Wandinger, Klaus-Peter, Leypoldt, Frank, Kümpfel, Tania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488759/
https://www.ncbi.nlm.nih.gov/pubmed/34599001
http://dx.doi.org/10.1212/NXI.0000000000001088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488759/
https://www.ncbi.nlm.nih.gov/pubmed/34599001
http://dx.doi.org/10.1212/NXI.0000000000001088

Ejemplares similares